Improved Titers against Influenza Drift Variants with a Nanoparticle Vaccine.
Shinde, Vivek; Fries, Louis; Wu, Yukun; Agrawal, Sapeckshita; Cho, Iksung; Thomas, D Nigel; Spindler, Michelle; Lindner, Elizabeth; Hahn, Timothy; Plested, Joyce; Flyer, David; Massare, Michael J; Zhou, Bin; Fix, Amy; Smith, Gale; Glenn, Gregory M.
N Engl J Med
; 378(24): 2346-2348, 2018 06 14.
Artigo em Inglês | MEDLINE | ID: mdl-29897849
Hemagglutinin Gene Clade 3C.2a Influenza A(H3N2) Viruses, Alachua County, Florida, USA, 2014-15.
[Characterization of a nonspecific inhibitor found in human sera raised against the 2006/07 influenza vaccine strain A/Hiroshima/52/2005 (H3N2) virus].
Antigenic Maps of Influenza A(H3N2) Produced With Human Antisera Obtained After Primary Infection.
Live attenuated and inactivated influenza vaccines in children.
Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination.
H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice.
A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine.
Matrix completion with side information and its applications in predicting the antigenicity of influenza viruses.
Impact of prior seasonal H3N2 influenza vaccination or infection on protection and transmission of emerging variants of influenza A(H3N2)v virus in ferrets.
Age-dependent prevalence of antibodies cross-reactive to the influenza A(H3N2) variant virus in sera collected in Norway in 2011.